This SMYD3-R265H mutant protein, which is predicted to be deleterious and was also found in a dataset of patients with CRC [67,68], shows a stronger interaction with ATM and localizes at DSBs like the wild-type form but is not able to interact with CHK2 and BRCA2. This evidence concerns the gene ATM and colorectal carcinoma.